Grafalon® vs. Thymoglobulin® as an induction agent in renal transplantation – A retrospective study
Introduction: Antihuman thymocyte immunoglobulin, used as an induction agent in renal transplantation, is of two types – thymoglobulin and grafalon (formerly ATG-Fresenius). In this study, we compared outcomes with these two agents. Methods: This was a single-center retrospective study of patients t...
Main Authors: | Pranaw Kumar Jha, Abhyudaysingh Rana, Ajay Kher, Shyam Bihari Bansal, Sidharth Sethi, Ashish Nandwani, Manish Jain, Dinesh Bansal, Dinesh Kumar Yadav, Ashwini Gadde, Amit Kumar Mahapatra, Puneet Sodhi, Vijay Kher |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2021;volume=31;issue=4;spage=336;epage=340;aulast=Jha |
Similar Items
-
Induction immunosuppression in kidney transplantation: Thymoglobulin® (a literature review)
by: A. V. Pinchuk
Published: (2016-02-01) -
Implication of thymoglobulin in kidney transplant patients: review article
by: Sudabeh Alatab, et al.
Published: (2015-11-01) -
Single dose thymoglobulin induction therapy in prevention of acute rejection in renal transplant
recipients
by: Georgi Abraham, et al.
Published: (2018-01-01) -
Basiliximab induction in living donor kidney transplant with tacrolimus-based triple immunosuppression
by: Shyam Bihari Bansal, et al.
Published: (2019-01-01) -
Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
by: Turun Song, et al.
Published: (2020-04-01)